Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-27

Clinical Trial Update: Effect of Arginine on Microcirculation in Patients With Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of arginine on microcirculation in patients with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arginine (L-Arginine)

Snippet

Sponsor: Tameside Hospital NHS Foundation Trust | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED